DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Dalakas MC, Rakocevic G, Salajegheh M , et al.
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
Ann Neurol 2009;
65 (3) 286-293
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.